| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | AURKA ERBB4 EPHA6 MAP4K3 NTRK2 STK33 PAK5 PAK4 PAK1 PAK2 AURKB DYRK2 | 8.96e-07 | 600 | 69 | 12 | GO:0004672 |
| GeneOntologyMolecularFunction | retinoic acid binding | 2.51e-06 | 28 | 69 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 4.26e-06 | 363 | 69 | 9 | GO:0106310 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | AURKA ERBB4 EPHA6 MAP4K3 NTRK2 STK33 PAK5 PAK4 PAK1 PAK2 AURKB DYRK2 | 5.04e-06 | 709 | 69 | 12 | GO:0016773 |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 6.31e-06 | 35 | 69 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | kinase activity | AURKA ERBB4 EPHA6 MAP4K3 NTRK2 STK33 PAK5 PAK4 PAK1 PAK2 AURKB DYRK2 | 1.07e-05 | 764 | 69 | 12 | GO:0016301 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 2.21e-05 | 446 | 69 | 9 | GO:0004674 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.27e-05 | 48 | 69 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.46e-05 | 49 | 69 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | AURKA ERBB4 EPHA6 MAP4K3 NTRK2 STK33 PAK5 PAK4 PAK1 PAK2 AURKB DYRK2 | 7.99e-05 | 938 | 69 | 12 | GO:0016772 |
| GeneOntologyMolecularFunction | protein homodimerization activity | UGT1A4 UGT1A3 ERBB4 UGT1A6 UGT1A5 NTRK2 ANO1 LRP6 MIGA1 NR6A1 GRM6 | 1.03e-04 | 815 | 69 | 11 | GO:0042803 |
| GeneOntologyMolecularFunction | L-ornithine transmembrane transporter activity | 1.17e-04 | 5 | 69 | 2 | GO:0000064 | |
| GeneOntologyMolecularFunction | protein dimerization activity | UGT1A4 UGT1A3 AURKA ERBB4 HIF1A UGT1A6 UGT1A5 NTRK2 ANO1 LRP6 MIGA1 NR6A1 GRM6 | 2.15e-04 | 1205 | 69 | 13 | GO:0046983 |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 4.17e-04 | 9 | 69 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 4.17e-04 | 9 | 69 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | L-lysine transmembrane transporter activity | 4.17e-04 | 9 | 69 | 2 | GO:0015189 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 4.42e-04 | 398 | 69 | 7 | GO:0046982 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 5.15e-04 | 107 | 69 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 5.74e-04 | 47 | 69 | 3 | GO:0004712 | |
| GeneOntologyMolecularFunction | histone H3 kinase activity | 7.60e-04 | 12 | 69 | 2 | GO:0140996 | |
| GeneOntologyMolecularFunction | L-arginine transmembrane transporter activity | 8.96e-04 | 13 | 69 | 2 | GO:0061459 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.48e-03 | 65 | 69 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.60e-03 | 145 | 69 | 4 | GO:0004713 | |
| GeneOntologyMolecularFunction | kinase binding | 1.74e-03 | 969 | 69 | 10 | GO:0019900 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.95e-03 | 153 | 69 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 2.15e-03 | 20 | 69 | 2 | GO:0015174 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 3.19e-03 | 85 | 69 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 3.91e-03 | 27 | 69 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | histone kinase activity | 4.20e-03 | 28 | 69 | 2 | GO:0035173 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 4.56e-03 | 599 | 69 | 7 | GO:0050839 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 6.57e-07 | 21 | 69 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.62e-06 | 26 | 69 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.62e-06 | 26 | 69 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 1.11e-05 | 228 | 69 | 7 | GO:0046777 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling, modulating synaptic transmission | 8.82e-05 | 26 | 69 | 3 | GO:0099550 | |
| GeneOntologyBiologicalProcess | pallium development | 9.90e-05 | 222 | 69 | 6 | GO:0021543 | |
| GeneOntologyBiologicalProcess | telencephalon development | 1.21e-04 | 332 | 69 | 7 | GO:0021537 | |
| GeneOntologyBiologicalProcess | cerebral cortex development | 1.34e-04 | 147 | 69 | 5 | GO:0021987 | |
| GeneOntologyBiologicalProcess | L-ornithine transmembrane transport | 1.64e-04 | 6 | 69 | 2 | GO:1903352 | |
| GeneOntologyBiologicalProcess | forebrain development | 2.22e-04 | 489 | 69 | 8 | GO:0030900 | |
| GeneOntologyBiologicalProcess | ornithine transport | 2.29e-04 | 7 | 69 | 2 | GO:0015822 | |
| GeneOntologyBiologicalProcess | learning or memory | 2.46e-04 | 373 | 69 | 7 | GO:0007611 | |
| GeneOntologyBiologicalProcess | L-arginine import across plasma membrane | 3.05e-04 | 8 | 69 | 2 | GO:0097638 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by lipid, modulating synaptic transmission | 3.05e-04 | 8 | 69 | 2 | GO:0099552 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by endocannabinoid, modulating synaptic transmission | 3.05e-04 | 8 | 69 | 2 | GO:0099553 | |
| GeneOntologyCellularComponent | chromosome passenger complex | 1.60e-04 | 6 | 69 | 2 | GO:0032133 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 3.31e-04 | 817 | 69 | 10 | GO:0098978 | |
| Domain | PAK_BD | 2.26e-09 | 6 | 67 | 4 | IPR033923 | |
| Domain | WASP_C | 5.25e-09 | 7 | 67 | 4 | IPR011026 | |
| Domain | Protein_kinase_ATP_BS | AURKA ERBB4 EPHA6 MAP4K3 NTRK2 STK33 PAK5 PAK4 PAK1 PAK2 AURKB DYRK2 | 9.00e-09 | 379 | 67 | 12 | IPR017441 |
| Domain | - | 7.33e-08 | 12 | 67 | 4 | 3.90.810.10 | |
| Domain | PROTEIN_KINASE_ATP | AURKA ERBB4 EPHA6 MAP4K3 NTRK2 STK33 PAK5 PAK4 PAK1 PAK2 AURKB DYRK2 | 7.41e-08 | 459 | 67 | 12 | PS00107 |
| Domain | Prot_kinase_dom | AURKA ERBB4 EPHA6 MAP4K3 NTRK2 STK33 PAK5 PAK4 PAK1 PAK2 AURKB DYRK2 | 1.47e-07 | 489 | 67 | 12 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | AURKA ERBB4 EPHA6 MAP4K3 NTRK2 STK33 PAK5 PAK4 PAK1 PAK2 AURKB DYRK2 | 1.61e-07 | 493 | 67 | 12 | PS50011 |
| Domain | PBD | 2.66e-07 | 16 | 67 | 4 | SM00285 | |
| Domain | PBD | 3.47e-07 | 17 | 67 | 4 | PF00786 | |
| Domain | Kinase-like_dom | AURKA ERBB4 EPHA6 MAP4K3 NTRK2 STK33 PAK5 PAK4 PAK1 PAK2 AURKB DYRK2 | 4.43e-07 | 542 | 67 | 12 | IPR011009 |
| Domain | CRIB | 7.02e-07 | 20 | 67 | 4 | PS50108 | |
| Domain | UDPGT | 8.64e-07 | 21 | 67 | 4 | PF00201 | |
| Domain | CRIB_dom | 8.64e-07 | 21 | 67 | 4 | IPR000095 | |
| Domain | UDPGT | 8.64e-07 | 21 | 67 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 8.64e-07 | 21 | 67 | 4 | IPR002213 | |
| Domain | Ser/Thr_kinase_AS | 4.96e-06 | 357 | 67 | 9 | IPR008271 | |
| Domain | S_TKc | 5.19e-06 | 359 | 67 | 9 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 5.55e-06 | 362 | 67 | 9 | PS00108 | |
| Domain | Pkinase | 8.38e-06 | 381 | 67 | 9 | PF00069 | |
| Domain | Aur | 3.79e-05 | 3 | 67 | 2 | IPR030616 | |
| Domain | Cat_AA_permease | 3.79e-05 | 3 | 67 | 2 | IPR004755 | |
| Domain | ATG_C | 1.26e-04 | 5 | 67 | 2 | PF09333 | |
| Domain | CAT3 | 1.26e-04 | 5 | 67 | 2 | IPR015606 | |
| Domain | AA_permease_C | 1.26e-04 | 5 | 67 | 2 | PF13906 | |
| Domain | CAT_C | 1.26e-04 | 5 | 67 | 2 | IPR029485 | |
| Domain | Autophagy-rel_C | 1.26e-04 | 5 | 67 | 2 | IPR015412 | |
| Domain | VPS13_N | 3.50e-04 | 8 | 67 | 2 | IPR026854 | |
| Domain | Chorein_N | 3.50e-04 | 8 | 67 | 2 | PF12624 | |
| Domain | GPCR_3_mtglu_rcpt | 3.50e-04 | 8 | 67 | 2 | IPR000162 | |
| Domain | NCD3G | 9.64e-04 | 13 | 67 | 2 | PF07562 | |
| Domain | AA_permease_2 | 9.64e-04 | 13 | 67 | 2 | PF13520 | |
| Domain | GPCR_3_9-Cys_dom | 9.64e-04 | 13 | 67 | 2 | IPR011500 | |
| Domain | AA/rel_permease1 | 9.64e-04 | 13 | 67 | 2 | IPR002293 | |
| Domain | GPCR_3_CS | 1.12e-03 | 14 | 67 | 2 | IPR017979 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 1.95e-03 | 69 | 67 | 3 | IPR020636 | |
| Domain | GPCR_3 | 2.55e-03 | 21 | 67 | 2 | IPR000337 | |
| Domain | - | 2.55e-03 | 21 | 67 | 2 | 3.30.230.10 | |
| Domain | AA-permease/SLC12A_dom | 2.80e-03 | 22 | 67 | 2 | IPR004841 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 2.80e-03 | 22 | 67 | 2 | IPR014721 | |
| Domain | 7tm_3 | 2.80e-03 | 22 | 67 | 2 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 2.80e-03 | 22 | 67 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 2.80e-03 | 22 | 67 | 2 | PS00981 | |
| Domain | AA_permease | 2.80e-03 | 22 | 67 | 2 | PF00324 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 2.80e-03 | 22 | 67 | 2 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 2.80e-03 | 22 | 67 | 2 | PS50259 | |
| Domain | GPCR_3_C | 2.80e-03 | 22 | 67 | 2 | IPR017978 | |
| Domain | TyrKc | 3.90e-03 | 88 | 67 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 3.90e-03 | 88 | 67 | 3 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 5.12e-03 | 97 | 67 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 5.12e-03 | 97 | 67 | 3 | IPR008266 | |
| Domain | Ribosomal_S5_D2-typ_fold | 6.60e-03 | 34 | 67 | 2 | IPR020568 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1 | 1.79e-07 | 13 | 58 | 4 | M6322 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 8.44e-07 | 43 | 58 | 5 | M39788 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 1.33e-06 | 47 | 58 | 5 | M39829 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.06e-06 | 25 | 58 | 4 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 3.06e-06 | 25 | 58 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 3.60e-06 | 26 | 58 | 4 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 4.91e-06 | 28 | 58 | 4 | M19580 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 7.86e-06 | 67 | 58 | 5 | M295 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 9.66e-06 | 33 | 58 | 4 | M6220 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 9.76e-06 | 70 | 58 | 5 | M13266 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 9.93e-06 | 121 | 58 | 6 | M39823 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 1.06e-05 | 439 | 58 | 10 | M42563 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 1.23e-05 | 35 | 58 | 4 | M16801 | |
| Pathway | REACTOME_RHOH_GTPASE_CYCLE | 1.38e-05 | 36 | 58 | 4 | MM15603 | |
| Pathway | REACTOME_RHOH_GTPASE_CYCLE | 1.54e-05 | 37 | 58 | 4 | M41813 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 2.11e-05 | 40 | 58 | 4 | M39798 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.33e-05 | 41 | 58 | 4 | M7399 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 2.82e-05 | 87 | 58 | 5 | M12467 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.90e-05 | 15 | 58 | 3 | MM15697 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.10e-05 | 44 | 58 | 4 | M45014 | |
| Pathway | SIG_CHEMOTAXIS | 3.39e-05 | 45 | 58 | 4 | M5193 | |
| Pathway | WP_ERBB_SIGNALING | 3.70e-05 | 92 | 58 | 5 | M39715 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 4.05e-05 | 155 | 58 | 6 | M41808 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 5.58e-05 | 51 | 58 | 4 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 6.03e-05 | 52 | 58 | 4 | M14171 | |
| Pathway | REACTOME_HEME_DEGRADATION | 7.17e-05 | 20 | 58 | 3 | MM14721 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 7.52e-05 | 55 | 58 | 4 | M14933 | |
| Pathway | WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA | 9.92e-05 | 59 | 58 | 4 | M39750 | |
| Pathway | WP_RAS_SIGNALING | 1.05e-04 | 184 | 58 | 6 | M39764 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.10e-04 | 23 | 58 | 3 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.26e-04 | 24 | 58 | 3 | MM14599 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.36e-04 | 64 | 58 | 4 | M9488 | |
| Pathway | WP_GLUCURONIDATION | 1.43e-04 | 25 | 58 | 3 | MM15820 | |
| Pathway | KEGG_AXON_GUIDANCE | 1.84e-04 | 129 | 58 | 5 | M5539 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.93e-04 | 70 | 58 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.15e-04 | 72 | 58 | 4 | M9257 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 2.74e-04 | 31 | 58 | 3 | MM1343 | |
| Pathway | PID_AURORA_A_PATHWAY | 2.74e-04 | 31 | 58 | 3 | M242 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.78e-04 | 220 | 58 | 6 | M10320 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 3.01e-04 | 32 | 58 | 3 | MM14719 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 4.45e-04 | 87 | 58 | 4 | MM15600 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 4.65e-04 | 37 | 58 | 3 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 4.65e-04 | 37 | 58 | 3 | MM15610 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 4.65e-04 | 88 | 58 | 4 | M41810 | |
| Pathway | WP_PANCREATIC_ADENOCARCINOMA_PATHWAY | 4.86e-04 | 89 | 58 | 4 | M39732 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 5.44e-04 | 39 | 58 | 3 | MM15607 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 5.86e-04 | 40 | 58 | 3 | M41816 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 7.50e-04 | 175 | 58 | 5 | MM15599 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 8.12e-04 | 102 | 58 | 4 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 8.12e-04 | 102 | 58 | 4 | MM15830 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 8.30e-04 | 45 | 58 | 3 | M39615 | |
| Pathway | REACTOME_ASPIRIN_ADME | 8.30e-04 | 45 | 58 | 3 | MM15694 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 8.85e-04 | 46 | 58 | 3 | M27397 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 9.16e-04 | 183 | 58 | 5 | M39588 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 9.39e-04 | 184 | 58 | 5 | M41809 | |
| Pathway | WP_MICROTUBULE_CYTOSKELETON_REGULATION | 1.00e-03 | 48 | 58 | 3 | M39566 | |
| Pathway | KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.01e-03 | 108 | 58 | 4 | M9904 | |
| Pathway | WP_FOCAL_ADHESION | 1.01e-03 | 187 | 58 | 5 | MM15913 | |
| Pathway | REACTOME_DRUG_ADME | 1.04e-03 | 109 | 58 | 4 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.04e-03 | 109 | 58 | 4 | M18788 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX | 1.07e-03 | 12 | 58 | 2 | M47887 | |
| Pathway | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | 1.07e-03 | 12 | 58 | 2 | M13618 | |
| Pathway | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | 1.07e-03 | 12 | 58 | 2 | MM14994 | |
| Pathway | REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION | 1.26e-03 | 13 | 58 | 2 | M27209 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.33e-03 | 199 | 58 | 5 | M7253 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.47e-03 | 14 | 58 | 2 | MM15029 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 1.49e-03 | 55 | 58 | 3 | M41815 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 1.65e-03 | 57 | 58 | 3 | M48326 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 1.69e-03 | 15 | 58 | 2 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 1.69e-03 | 15 | 58 | 2 | MM15845 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 1.74e-03 | 58 | 58 | 3 | MM15602 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 1.82e-03 | 59 | 58 | 3 | M41812 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.92e-03 | 16 | 58 | 2 | M16498 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.03e-03 | 219 | 58 | 5 | MM14838 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 2.17e-03 | 17 | 58 | 2 | MM15215 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.38e-03 | 450 | 58 | 7 | M27078 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 2.41e-03 | 65 | 58 | 3 | MM14911 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 2.44e-03 | 18 | 58 | 2 | MM15024 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 2.44e-03 | 18 | 58 | 2 | M39424 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 2.53e-03 | 720 | 58 | 9 | M41838 | |
| Pathway | WP_NRF2_PATHWAY | 2.68e-03 | 141 | 58 | 4 | M39454 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 2.72e-03 | 19 | 58 | 2 | M27310 | |
| Pathway | PID_CDC42_PATHWAY | 2.98e-03 | 70 | 58 | 3 | M81 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 3.10e-03 | 71 | 58 | 3 | MM15604 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 3.32e-03 | 21 | 58 | 2 | M27485 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 3.32e-03 | 21 | 58 | 2 | M27494 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 3.35e-03 | 150 | 58 | 4 | M39520 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 3.48e-03 | 74 | 58 | 3 | M41814 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 3.51e-03 | 152 | 58 | 4 | MM15834 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 3.59e-03 | 153 | 58 | 4 | MM15844 | |
| Pathway | WP_ESTROGEN_METABOLISM | 3.65e-03 | 22 | 58 | 2 | MM15888 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 3.76e-03 | 76 | 58 | 3 | MM1433 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 3.98e-03 | 23 | 58 | 2 | MM15222 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 3.98e-03 | 23 | 58 | 2 | M47910 | |
| Pathway | PID_MET_PATHWAY | 4.19e-03 | 79 | 58 | 3 | M48 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 4.49e-03 | 81 | 58 | 3 | M13863 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 4.70e-03 | 25 | 58 | 2 | M47934 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 4.84e-03 | 649 | 58 | 8 | MM15690 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 5.47e-03 | 27 | 58 | 2 | MM14809 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 5.47e-03 | 27 | 58 | 2 | M27422 | |
| Pubmed | Targeted disruption of the gene for the PAK5 kinase in mice. | 2.12e-10 | 6 | 69 | 4 | 14517284 | |
| Pubmed | 1.77e-09 | 9 | 69 | 4 | 22511988 | ||
| Pubmed | 1.77e-09 | 9 | 69 | 4 | 1339448 | ||
| Pubmed | 2.95e-09 | 10 | 69 | 4 | 23642732 | ||
| Pubmed | 2.95e-09 | 10 | 69 | 4 | 11465080 | ||
| Pubmed | 2.95e-09 | 10 | 69 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 2.95e-09 | 10 | 69 | 4 | 22558097 | |
| Pubmed | 6.94e-09 | 12 | 69 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 6.94e-09 | 12 | 69 | 4 | 11434514 | |
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 26218748 | ||
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.00e-08 | 13 | 69 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.00e-08 | 13 | 69 | 4 | 25246029 | |
| Pubmed | 1.40e-08 | 14 | 69 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.40e-08 | 14 | 69 | 4 | 10836148 | |
| Pubmed | 1.40e-08 | 14 | 69 | 4 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.40e-08 | 14 | 69 | 4 | 14672974 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 2.54e-08 | 16 | 69 | 4 | 19414484 | |
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 10461188 | ||
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 26423403 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 3.31e-08 | 17 | 69 | 4 | 20639394 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 5.38e-08 | 19 | 69 | 4 | 23281178 | |
| Pubmed | Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. | 7.45e-08 | 5 | 69 | 3 | 23509247 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 1.46e-07 | 24 | 69 | 4 | 24625756 | |
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 1.49e-07 | 6 | 69 | 3 | 19204906 | |
| Pubmed | 4.16e-07 | 8 | 69 | 3 | 20610558 | ||
| Pubmed | 4.16e-07 | 8 | 69 | 3 | 22579593 | ||
| Pubmed | 4.16e-07 | 8 | 69 | 3 | 17179145 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.62e-06 | 12 | 69 | 3 | 20308471 | |
| Pubmed | 1.62e-06 | 12 | 69 | 3 | 18161889 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 25882311 | ||
| Pubmed | Activation of PAK1/2 during the shedding of platelet microvesicles. | 3.88e-06 | 2 | 69 | 2 | 20523167 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 23114921 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 8068691 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 16912073 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 23092930 | ||
| Pubmed | Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary gland. | 3.88e-06 | 2 | 69 | 2 | 24966332 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 38797819 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 25807528 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 22222631 | ||
| Pubmed | p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma. | 3.88e-06 | 2 | 69 | 2 | 33414491 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 24641623 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 27249336 | ||
| Pubmed | Mitotic kinases as regulators of cell division and its checkpoints. | 3.88e-06 | 2 | 69 | 2 | 11413462 | |
| Pubmed | Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases. | 3.88e-06 | 2 | 69 | 2 | 10523496 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 20865660 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 23966163 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 20732714 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 22463590 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 15047871 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 28684763 | ||
| Pubmed | The importance of cationic amino acid transporter expression in human skin. | 3.88e-06 | 2 | 69 | 2 | 12787129 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 31597600 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 19059698 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 9174363 | ||
| Pubmed | Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target. | 3.88e-06 | 2 | 69 | 2 | 22940834 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 32597567 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 31391252 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26808391 | ||
| Pubmed | Aurora kinases as prognostic biomarkers in ovarian carcinoma. | 3.88e-06 | 2 | 69 | 2 | 19157502 | |
| Pubmed | Antiproliferative effect of Aurora kinase targeting in mesothelioma. | 3.88e-06 | 2 | 69 | 2 | 20371132 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 8195186 | ||
| Pubmed | Spatial Compartmentalization Specializes the Function of Aurora A and Aurora B. | 3.88e-06 | 2 | 69 | 2 | 25987563 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 25436453 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 12244066 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 18635166 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 16572587 | ||
| Pubmed | Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling. | 3.88e-06 | 2 | 69 | 2 | 22308027 | |
| Pubmed | PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions. | 3.88e-06 | 2 | 69 | 2 | 31748572 | |
| Pubmed | Aurora kinases as targets in drug-resistant neuroblastoma cells. | 3.88e-06 | 2 | 69 | 2 | 25268132 | |
| Pubmed | Differential role for PAK1 and PAK4 during the invadopodia lifecycle. | 3.88e-06 | 2 | 69 | 2 | 28301299 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 19435845 | ||
| Pubmed | Human cationic amino acid transporters are not affected by direct nitros(yl)ation. | 3.88e-06 | 2 | 69 | 2 | 32008093 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 24683001 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 33277547 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 23925655 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 28410202 | ||
| Pubmed | Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. | 3.88e-06 | 2 | 69 | 2 | 11784863 | |
| Pubmed | Identification of a low affinity, high capacity transporter of cationic amino acids in mouse liver. | 3.88e-06 | 2 | 69 | 2 | 8385111 | |
| Pubmed | Association of the AURKA and AURKC gene polymorphisms with an increased risk of gastric cancer. | 3.88e-06 | 2 | 69 | 2 | 27270838 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 28843004 | ||
| Pubmed | P21-activated kinase 1 and 4 were associated with colorectal cancer metastasis and infiltration. | 3.88e-06 | 2 | 69 | 2 | 25791829 | |
| Pubmed | Aurora kinase A and B as new treatment targets in aromatase inhibitor-resistant breast cancer cells. | 3.88e-06 | 2 | 69 | 2 | 25667100 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 33172929 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 20368716 | ||
| Pubmed | Regulation of cationic amino acid transporter (CAT) gene expression. | 3.88e-06 | 2 | 69 | 2 | 8878860 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 21858073 | ||
| Pubmed | Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer. | 3.88e-06 | 2 | 69 | 2 | 18628459 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 15064952 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 27143691 | ||
| Pubmed | Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity. | 3.88e-06 | 2 | 69 | 2 | 33123754 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 23788275 | ||
| Pubmed | p21-activated kinase 4 regulates HIF-1α translation in cancer cells. | 3.88e-06 | 2 | 69 | 2 | 28288786 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 11950587 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26141684 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26443806 | ||
| Pubmed | Allosteric modulation of a human protein kinase with monobodies. | 3.88e-06 | 2 | 69 | 2 | 31239342 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 34750857 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26660542 | ||
| Pubmed | PAK5 promotes the cell stemness ability by phosphorylating SOX2 in lung squamous cell carcinomas. | 3.88e-06 | 2 | 69 | 2 | 32721391 | |
| Pubmed | Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. | 3.88e-06 | 2 | 69 | 2 | 9395435 | |
| Interaction | ZSWIM8 interactions | 5.07e-06 | 74 | 68 | 5 | int:ZSWIM8 | |
| Interaction | RAC2 interactions | AURKA SLC7A1 SLC7A2 DOCK11 PAK4 PAK1 PAK2 MIGA1 PIGU ANKLE2 VPS13B | 1.46e-05 | 674 | 68 | 11 | int:RAC2 |
| Interaction | LIMK1 interactions | 1.91e-05 | 97 | 68 | 5 | int:LIMK1 | |
| Interaction | ETV6 interactions | 2.80e-05 | 105 | 68 | 5 | int:ETV6 | |
| Cytoband | 2q37 | 1.43e-07 | 31 | 69 | 4 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 3.85e-04 | 226 | 69 | 4 | chr2q37 | |
| Cytoband | 3q11.2 | 7.07e-04 | 26 | 69 | 2 | 3q11.2 | |
| Cytoband | 20q11.22 | 1.43e-03 | 37 | 69 | 2 | 20q11.22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q11 | 3.03e-03 | 54 | 69 | 2 | chr3q11 | |
| GeneFamily | UDP glucuronosyltransferases | 1.37e-06 | 32 | 47 | 4 | 363 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.83e-04 | 8 | 47 | 2 | 281 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS | 1.73e-06 | 77 | 68 | 5 | M40001 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.51e-06 | 174 | 69 | 5 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.94e-06 | 176 | 69 | 5 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.85e-06 | 184 | 69 | 5 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.09e-05 | 188 | 69 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.18e-05 | 191 | 69 | 5 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | IPF-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 1.21e-05 | 192 | 69 | 5 | 9b06c7336624ef21f8e5393725b56038a8028e57 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 192 | 69 | 5 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 192 | 69 | 5 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.27e-05 | 194 | 69 | 5 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 196 | 69 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-05 | 196 | 69 | 5 | 1d94cecd378a829dd8014fc086d7fca48c953a91 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-05 | 196 | 69 | 5 | aacec48285bcb7ccf1b538187071885e3602cc49 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 198 | 69 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 198 | 69 | 5 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-05 | 199 | 69 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.44e-05 | 199 | 69 | 5 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.47e-05 | 200 | 69 | 5 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Neuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.47e-05 | 200 | 69 | 5 | 9ff8647e2de0b538e15929dca88ebb20ff7ab043 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 200 | 69 | 5 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-05 | 145 | 69 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 7.81e-05 | 146 | 69 | 4 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-04 | 162 | 69 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.19e-04 | 163 | 69 | 4 | e4077e587895c85bc806be05ff5d451088e39468 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.22e-04 | 164 | 69 | 4 | 81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 168 | 69 | 4 | 9b8a74abb83c64f0b5829dcb4275f722c82b45dc | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 168 | 69 | 4 | 4b152b8d0f4a66faf664dfacb7914b18d60ce64a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 168 | 69 | 4 | c3169ad8f4130ef18777ed86770bb722ffb5db85 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-04 | 169 | 69 | 4 | 3f738fc56bbc70dc77c9ba41025631f8264cd2b3 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 169 | 69 | 4 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 169 | 69 | 4 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-04 | 170 | 69 | 4 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 1.44e-04 | 171 | 69 | 4 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 173 | 69 | 4 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 175 | 69 | 4 | 294a70786260c9a2b1ba16c88819d786698609e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 175 | 69 | 4 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 175 | 69 | 4 | 798f33bd340261c048b7b45c842b2ccd1ea1fb60 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 175 | 69 | 4 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-04 | 175 | 69 | 4 | 9d797888edb39fd12fd9cfc698a42b7bed19a5b5 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-04 | 177 | 69 | 4 | d731400997afea379f47ae8aa0f82802962b0861 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 179 | 69 | 4 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | Control-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.71e-04 | 179 | 69 | 4 | 9383568f78b07b8cca72ece5d15fea209aa54ea9 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-04 | 181 | 69 | 4 | 2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-04 | 183 | 69 | 4 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.90e-04 | 184 | 69 | 4 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-04 | 184 | 69 | 4 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.90e-04 | 184 | 69 | 4 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.90e-04 | 184 | 69 | 4 | 9c56753e5e668be888662e4713cf4ce44e6c58fb | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-lung_neuroendocrine_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 185 | 69 | 4 | 30263c558ee331e0879abcf8b4c2427ff05f9fe7 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Neuroendocrine|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 185 | 69 | 4 | 1b000ca11970db8f347eb97ff44605d562aea70a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-04 | 187 | 69 | 4 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.02e-04 | 187 | 69 | 4 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 2.02e-04 | 187 | 69 | 4 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-04 | 188 | 69 | 4 | 0a5b93c131ce8514e996b0c2f39e0fc98636c122 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-Early_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.06e-04 | 188 | 69 | 4 | 6151051c027c7ff7d5d4bf5f1e11d7fe58eb22ed | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-04 | 188 | 69 | 4 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-04 | 188 | 69 | 4 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-04 | 188 | 69 | 4 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 189 | 69 | 4 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.11e-04 | 189 | 69 | 4 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 190 | 69 | 4 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 190 | 69 | 4 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-04 | 190 | 69 | 4 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 190 | 69 | 4 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 190 | 69 | 4 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 190 | 69 | 4 | be2b184a3559da41ba387ae0fdbeb9ae532868a5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 190 | 69 | 4 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 190 | 69 | 4 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.19e-04 | 191 | 69 | 4 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-04 | 191 | 69 | 4 | f631749ef1f2270133664cf5eb4cf545a8482bd3 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.19e-04 | 191 | 69 | 4 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.19e-04 | 191 | 69 | 4 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 2.19e-04 | 191 | 69 | 4 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.19e-04 | 191 | 69 | 4 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.19e-04 | 191 | 69 | 4 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.19e-04 | 191 | 69 | 4 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.19e-04 | 191 | 69 | 4 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.19e-04 | 191 | 69 | 4 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.19e-04 | 191 | 69 | 4 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 191 | 69 | 4 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | Control-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 2.19e-04 | 191 | 69 | 4 | 2da83c493e60ad0278848957645277d76737a188 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.19e-04 | 191 | 69 | 4 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class （2021.01.30） | 2.19e-04 | 191 | 69 | 4 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.19e-04 | 191 | 69 | 4 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.19e-04 | 191 | 69 | 4 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30） | 2.19e-04 | 191 | 69 | 4 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 2.19e-04 | 191 | 69 | 4 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 192 | 69 | 4 | d2161842a38146261847fc9061ba9322e0f087e0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-04 | 192 | 69 | 4 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 192 | 69 | 4 | 261211a86e6f63b09c2ddce1d2d9257d311f1770 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-04 | 192 | 69 | 4 | 7aadc7c5bd03274f9861dde2febda5c37f8afc9c | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-04 | 192 | 69 | 4 | 5a3c66fc3ae22bd9ac90ca137dee0bcabcd20ab8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-04 | 192 | 69 | 4 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-04 | 192 | 69 | 4 | 1f348e23843405abb1f1dc7d739fc5647333de16 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-04 | 192 | 69 | 4 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 192 | 69 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.28e-04 | 193 | 69 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 193 | 69 | 4 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.28e-04 | 193 | 69 | 4 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| Drug | AC1MRQNQ | 9.06e-09 | 9 | 68 | 4 | CID003522271 | |
| Drug | DHPASiU | 9.06e-09 | 9 | 68 | 4 | CID000197602 | |
| Drug | Chebi:32663 | 9.06e-09 | 9 | 68 | 4 | CID005460873 | |
| Drug | 3-iodophenol | 9.06e-09 | 9 | 68 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 9.06e-09 | 9 | 68 | 4 | CID000186631 | |
| Drug | N-phenylmaleimide | 1.04e-08 | 25 | 68 | 5 | CID000013662 | |
| Drug | 4-nitrophenyl)imidazole | 2.36e-08 | 11 | 68 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 2.36e-08 | 11 | 68 | 4 | CID006442661 | |
| Drug | N-OH-DABZ | 3.54e-08 | 12 | 68 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 3.54e-08 | 12 | 68 | 4 | CID000088735 | |
| Drug | 2,4,6-TCB | 3.54e-08 | 12 | 68 | 4 | CID000037247 | |
| Drug | 7,7,7-triphenylheptanoic acid | 3.54e-08 | 12 | 68 | 4 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 3.54e-08 | 12 | 68 | 4 | CID000160090 | |
| Drug | tritanol | 5.10e-08 | 13 | 68 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 5.10e-08 | 13 | 68 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 5.10e-08 | 13 | 68 | 4 | CID000000411 | |
| Drug | propranolol glucuronide | 7.12e-08 | 14 | 68 | 4 | CID000119515 | |
| Drug | PCB-61 | 7.12e-08 | 14 | 68 | 4 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 9.69e-08 | 15 | 68 | 4 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 9.69e-08 | 15 | 68 | 4 | CID000010752 | |
| Drug | sulforaphane nitrile | 9.69e-08 | 15 | 68 | 4 | CID000543743 | |
| Drug | afloqualone | 9.69e-08 | 15 | 68 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 9.69e-08 | 15 | 68 | 4 | CID000114775 | |
| Drug | quercetin-3,4'-diglucoside | 1.29e-07 | 16 | 68 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 1.29e-07 | 16 | 68 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 1.29e-07 | 16 | 68 | 4 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.68e-07 | 17 | 68 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 1.68e-07 | 17 | 68 | 4 | CID000037766 | |
| Drug | MS-222 | 2.03e-07 | 44 | 68 | 5 | CID000011400 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 2.16e-07 | 18 | 68 | 4 | CID000152226 | |
| Drug | Br 2 | 2.16e-07 | 18 | 68 | 4 | CID003060900 | |
| Drug | SureCN12722713 | 2.16e-07 | 18 | 68 | 4 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 2.16e-07 | 18 | 68 | 4 | CID000036614 | |
| Drug | ApApG | 2.16e-07 | 18 | 68 | 4 | CID003081975 | |
| Drug | C1 11-32 | 2.16e-07 | 18 | 68 | 4 | CID000443077 | |
| Drug | C11131 | 2.16e-07 | 18 | 68 | 4 | CID000443076 | |
| Drug | almokalant | 2.73e-07 | 19 | 68 | 4 | CID003033962 | |
| Drug | 9-OH-risperidone | 2.73e-07 | 19 | 68 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 2.73e-07 | 19 | 68 | 4 | CID000091433 | |
| Drug | isoamyl alcohol | 3.17e-07 | 48 | 68 | 5 | CID000031260 | |
| Drug | tectochrysin | 3.40e-07 | 20 | 68 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 3.40e-07 | 20 | 68 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 3.40e-07 | 20 | 68 | 4 | CID000116545 | |
| Drug | estriol-16-glucuronide | 4.19e-07 | 21 | 68 | 4 | CID000122281 | |
| Drug | dulcin | 4.19e-07 | 21 | 68 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 4.19e-07 | 21 | 68 | 4 | CID000069186 | |
| Drug | levo-dromoran tartrate | 4.81e-07 | 98 | 68 | 6 | CID000003918 | |
| Drug | amonafide | 5.11e-07 | 22 | 68 | 4 | CID000050515 | |
| Drug | N-methylpiperazine | 5.11e-07 | 22 | 68 | 4 | CID000053167 | |
| Drug | amidoxime | 6.17e-07 | 23 | 68 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 6.17e-07 | 23 | 68 | 4 | CID000066651 | |
| Drug | phenanthridine | 6.17e-07 | 23 | 68 | 4 | CID000009189 | |
| Drug | AS-3201 | 7.39e-07 | 24 | 68 | 4 | CID000153948 | |
| Drug | norclozapine | 7.60e-07 | 57 | 68 | 5 | CID000002820 | |
| Drug | 5-MOP | 8.78e-07 | 25 | 68 | 4 | CID000002355 | |
| Drug | AzMC | 8.78e-07 | 25 | 68 | 4 | CID000064986 | |
| Drug | N-acetylbenzidine | 8.78e-07 | 25 | 68 | 4 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 8.78e-07 | 25 | 68 | 4 | CID000006796 | |
| Drug | acetaminophen glucuronide | 9.04e-07 | 59 | 68 | 5 | CID000083944 | |
| Drug | DiMeIQx | 1.21e-06 | 27 | 68 | 4 | CID000104739 | |
| Drug | diflunisal | 1.21e-06 | 27 | 68 | 4 | CID000003059 | |
| Drug | ketoprofen | 1.36e-06 | 64 | 68 | 5 | CID000003825 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.41e-06 | 28 | 68 | 4 | CID000081261 | |
| Drug | CARMINE | 1.41e-06 | 28 | 68 | 4 | CID000014749 | |
| Drug | erucin | 1.41e-06 | 28 | 68 | 4 | CID000078160 | |
| Drug | H-Ni | 1.41e-06 | 28 | 68 | 4 | CID000445665 | |
| Drug | i 143 | 1.41e-06 | 8 | 68 | 3 | CID002777991 | |
| Drug | AC1L1JAL | 1.63e-06 | 29 | 68 | 4 | CID000004954 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 1.63e-06 | 29 | 68 | 4 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 1.63e-06 | 29 | 68 | 4 | CID000000414 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.63e-06 | 29 | 68 | 4 | CID000125641 | |
| Drug | iberin | 1.63e-06 | 29 | 68 | 4 | CID000010455 | |
| Drug | tolcapone | 1.88e-06 | 30 | 68 | 4 | CID004659569 | |
| Drug | paricalcitol | 1.88e-06 | 30 | 68 | 4 | CID005281104 | |
| Drug | AC1L9E0Q | 1.88e-06 | 30 | 68 | 4 | CID000443095 | |
| Drug | dihydroartemisinin | 1.88e-06 | 30 | 68 | 4 | CID000107770 | |
| Drug | 4-ethylphenol | 2.15e-06 | 31 | 68 | 4 | CID000031242 | |
| Drug | PCB 156 | 2.15e-06 | 31 | 68 | 4 | CID000038019 | |
| Drug | 4'-HPPH | 2.15e-06 | 31 | 68 | 4 | CID000017732 | |
| Drug | indole-2-carboxylic acid | 2.46e-06 | 32 | 68 | 4 | CID000072899 | |
| Drug | NNAL | 2.46e-06 | 32 | 68 | 4 | CID000104856 | |
| Drug | Muracein C | 2.46e-06 | 32 | 68 | 4 | CID003086323 | |
| Drug | AC1Q6OQG | 2.79e-06 | 33 | 68 | 4 | CID000009686 | |
| Drug | R(-)-Denopamine | 2.79e-06 | 33 | 68 | 4 | CID000003818 | |
| Drug | 6-methylsalicylic acid | 2.79e-06 | 33 | 68 | 4 | CID000011279 | |
| Drug | BP-3,6-quinol | 2.79e-06 | 33 | 68 | 4 | CID000119292 | |
| Drug | norbuprenorphine | 2.79e-06 | 33 | 68 | 4 | CID000114976 | |
| Drug | geniposide | 2.79e-06 | 33 | 68 | 4 | CID000107848 | |
| Drug | estragole | 3.15e-06 | 34 | 68 | 4 | CID000008815 | |
| Drug | AC1NOWCJ | 3.55e-06 | 35 | 68 | 4 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 3.55e-06 | 35 | 68 | 4 | CID010436171 | |
| Drug | estrone-3-glucuronide | 3.55e-06 | 35 | 68 | 4 | CID000115255 | |
| Drug | benzyloxyresorufin | 3.65e-06 | 78 | 68 | 5 | CID000114982 | |
| Drug | 4-hydroxyestradiol | 3.89e-06 | 79 | 68 | 5 | CID000001743 | |
| Drug | AC1L9DGV | 3.99e-06 | 36 | 68 | 4 | CID000417381 | |
| Drug | muraglitazar | 3.99e-06 | 36 | 68 | 4 | CID000206044 | |
| Drug | anisole | 3.99e-06 | 36 | 68 | 4 | CID000007519 | |
| Drug | glucoraphanin | 3.99e-06 | 36 | 68 | 4 | CID000656556 | |
| Drug | bevirimat | 3.99e-06 | 36 | 68 | 4 | CID000457928 | |
| Drug | acotiamide | 4.46e-06 | 37 | 68 | 4 | CID005282338 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.79e-09 | 8 | 68 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.79e-09 | 8 | 68 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.79e-09 | 8 | 68 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.79e-09 | 8 | 68 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.79e-09 | 8 | 68 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.79e-09 | 8 | 68 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.79e-09 | 8 | 68 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.79e-09 | 8 | 68 | 4 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.79e-09 | 8 | 68 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.79e-09 | 8 | 68 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 3.22e-09 | 9 | 68 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.22e-09 | 9 | 68 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.22e-09 | 9 | 68 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 3.22e-09 | 9 | 68 | 4 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 3.22e-09 | 9 | 68 | 4 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 3.22e-09 | 9 | 68 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 3.22e-09 | 9 | 68 | 4 | EFO_0800698 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.22e-09 | 9 | 68 | 4 | EFO_0004570, GO_0009410 | |
| Disease | protein-tyrosine kinase 6 measurement | 3.22e-09 | 9 | 68 | 4 | EFO_0020691 | |
| Disease | X-21448 measurement | 5.36e-09 | 10 | 68 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 5.36e-09 | 10 | 68 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 5.36e-09 | 10 | 68 | 4 | EFO_0800867 | |
| Disease | bilirubin measurement, response to tenofovir | 5.36e-09 | 10 | 68 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-21796 measurement | 8.41e-09 | 11 | 68 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 8.41e-09 | 11 | 68 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 8.41e-09 | 11 | 68 | 4 | EFO_0800972 | |
| Disease | aldosterone measurement | 8.41e-09 | 11 | 68 | 4 | EFO_0010219 | |
| Disease | biliverdin measurement | 1.26e-08 | 12 | 68 | 4 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 1.26e-08 | 12 | 68 | 4 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 1.82e-08 | 13 | 68 | 4 | EFO_0802007 | |
| Disease | cholelithiasis | 5.58e-08 | 88 | 68 | 6 | EFO_0004799 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 6.00e-08 | 17 | 68 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 7.70e-08 | 18 | 68 | 4 | EFO_0801382 | |
| Disease | tissue factor measurement | 1.50e-07 | 21 | 68 | 4 | EFO_0010623 | |
| Disease | urate measurement, spine bone mineral density | 2.33e-07 | 58 | 68 | 5 | EFO_0004531, EFO_0007701 | |
| Disease | xanthurenate measurement | 5.86e-07 | 29 | 68 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 6.76e-07 | 30 | 68 | 4 | EFO_0600017 | |
| Disease | thyroxine measurement | 1.41e-06 | 83 | 68 | 5 | EFO_0005130 | |
| Disease | pregnenetriol sulfate measurement | 1.91e-06 | 11 | 68 | 3 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.91e-06 | 11 | 68 | 3 | EFO_0600039 | |
| Disease | pregnenetriol disulfate measurement | 3.29e-06 | 13 | 68 | 3 | EFO_0800587 | |
| Disease | gallstones | 5.19e-06 | 108 | 68 | 5 | EFO_0004210 | |
| Disease | Malignant neoplasm of breast | AURKA RGL1 EEF2 ERBB4 HIF1A WDCP SURF1 NUP98 PAK1 MRPL13 GRM6 VPS13B | 5.65e-06 | 1074 | 68 | 12 | C0006142 |
| Disease | X-21441 measurement | 7.78e-06 | 17 | 68 | 3 | EFO_0800814 | |
| Disease | hormone measurement | 4.33e-05 | 84 | 68 | 4 | EFO_0004730 | |
| Disease | arabinose measurement | 1.09e-04 | 7 | 68 | 2 | EFO_0021030 | |
| Disease | serum N-desmethylclozapine measurement | 1.45e-04 | 8 | 68 | 2 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 1.45e-04 | 8 | 68 | 2 | EFO_0600038 | |
| Disease | renal cell carcinoma (is_marker_for) | 2.22e-04 | 128 | 68 | 4 | DOID:4450 (is_marker_for) | |
| Disease | morbid obesity (is_marker_for) | 2.33e-04 | 10 | 68 | 2 | DOID:11981 (is_marker_for) | |
| Disease | monoclonal gammopathy | 2.52e-04 | 53 | 68 | 3 | EFO_0000203 | |
| Disease | pallidum volume change measurement | 4.02e-04 | 13 | 68 | 2 | EFO_0021494 | |
| Disease | transitional cell carcinoma (is_marker_for) | 4.21e-04 | 63 | 68 | 3 | DOID:2671 (is_marker_for) | |
| Disease | bilirubin measurement | 5.46e-04 | 442 | 68 | 6 | EFO_0004570 | |
| Disease | susceptibility to childhood ear infection measurement | 6.64e-04 | 171 | 68 | 4 | EFO_0007904 | |
| Disease | breast cancer (is_marker_for) | 8.91e-04 | 185 | 68 | 4 | DOID:1612 (is_marker_for) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.08e-03 | 195 | 68 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | age-related macular degeneration | 1.15e-03 | 89 | 68 | 3 | EFO_0001365 | |
| Disease | Adenocarcinoma of large intestine | 1.43e-03 | 96 | 68 | 3 | C1319315 | |
| Disease | Breast Carcinoma | 1.50e-03 | 538 | 68 | 6 | C0678222 | |
| Disease | Cerebral Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0750936 | |
| Disease | colon adenocarcinoma (is_marker_for) | 1.52e-03 | 25 | 68 | 2 | DOID:234 (is_marker_for) | |
| Disease | Pilocytic Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0334583 | |
| Disease | Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.52e-03 | 25 | 68 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0338070 | |
| Disease | brain cancer (implicated_via_orthology) | 1.64e-03 | 26 | 68 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | Gemistocytic astrocytoma | 1.64e-03 | 26 | 68 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.64e-03 | 26 | 68 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.64e-03 | 26 | 68 | 2 | C0334582 | |
| Disease | blood rubidium measurement | 1.64e-03 | 26 | 68 | 2 | EFO_0021529 | |
| Disease | malaria | 1.71e-03 | 102 | 68 | 3 | EFO_0001068 | |
| Disease | Anaplastic astrocytoma | 1.77e-03 | 27 | 68 | 2 | C0334579 | |
| Disease | prostate carcinoma in situ (is_marker_for) | 1.90e-03 | 28 | 68 | 2 | DOID:8634 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LFRGDFVMDYPRPIM | 256 | P35503 | |
| MLRLYPGPMVTEAEG | 1 | P0C7Q2 | |
| PRGELDEEGYMTPMR | 1141 | Q15303 | |
| LDVLENPDFMRLMYP | 371 | Q86XL3 | |
| GTLDYLPPEMIEGRM | 291 | O14965 | |
| YEAVPPMIEMGRIHK | 1561 | Q68DQ2 | |
| LFQEMAIDIIPPYMI | 206 | O94805 | |
| MGLFMVRPLATEYPP | 4241 | Q86UQ4 | |
| NMEELILALFMPPTY | 246 | P20073 | |
| DRVAIYMPMIPELVV | 161 | Q9NR19 | |
| VFYPDPMMVTRQEDL | 476 | P55290 | |
| SIFPMPRVIYAMAED | 356 | P52569 | |
| RTMYETEEMVIPGDP | 781 | Q2TAZ0 | |
| LLDYLTRMMPGSDPE | 171 | Q9NZL6 | |
| IMVIEMIDGEPPYFN | 631 | Q9P286 | |
| PLRMFEMLVVPEQEY | 721 | Q8IVH8 | |
| HIGRLPMPEDYAMDE | 1786 | P52948 | |
| RFPLMEVYDPDVGMN | 151 | Q9Y5G7 | |
| GIIVALFIMEPPDIM | 706 | P41594 | |
| DILGPPMYEMEVSQR | 636 | Q86WA8 | |
| MLAPYIPMDDDFQLR | 561 | Q16665 | |
| DGEDIPREMLMGIYE | 691 | Q6DN90 | |
| MTPRVPMERELSFYG | 186 | Q9BUM1 | |
| EEPRAIVLDPMVGYM | 446 | O75581 | |
| PFAGLTPEYMEMIIQ | 721 | Q5XXA6 | |
| PEPGQGTEDRFVMYM | 2771 | O15230 | |
| EALPPEMVTRLYDGM | 56 | Q6P9B6 | |
| PDVAELIRTPMEMRY | 121 | Q9H490 | |
| GIMAIEMIEGEPPYL | 451 | Q13153 | |
| IMAIEMVEGEPPYLN | 431 | Q13177 | |
| MGLPPYDPIRMEFEN | 156 | P57076 | |
| PAMEPTDGRMLLQYI | 431 | O15303 | |
| IYSDPLRDLLMFPME | 56 | Q5JSL3 | |
| FMNVDLRERFAYPMP | 226 | Q9Y6W3 | |
| RVLPMYAGLPSFEQM | 311 | Q9H5Z1 | |
| ILMMGRYVEPIEDVP | 451 | P13639 | |
| LDVPPEMMPTVIDEY | 381 | Q6UWW8 | |
| RLEVPVEMNPEGYMT | 191 | P50895 | |
| PEVILGARYGMPIDM | 391 | Q92630 | |
| LGIMVIEMVDGEPPY | 501 | O96013 | |
| IPAGRPVMIVVEYME | 741 | Q9UF33 | |
| IPVTTPENLYLMGME | 201 | Q8NAN2 | |
| RFPDLMMCLPEIRYI | 436 | Q15406 | |
| NRDYVPMMVELLGPE | 261 | P0C091 | |
| RDMISMYLPGAEVPE | 271 | P48431 | |
| RPGYPIDLFMVEIME | 181 | Q92526 | |
| VVMYMLLRGEPPFLA | 311 | Q9BYT3 | |
| ELYMMPRTMVDPVRE | 131 | Q15526 | |
| VGDPYVPLMVLMCRV | 251 | Q8TC41 | |
| MSVFDAYMEPGPRRQ | 106 | Q8NCG5 | |
| TLDYLPPEMIEGRMH | 236 | Q96GD4 | |
| VCVEGDPLIMVFEYM | 606 | Q16620 | |
| EASFPRMEGMLFLPV | 296 | Q7Z2Z1 | |
| DMEAYVLRPALPGTM | 271 | O00295 | |
| FPMPRVIYAMAEDGL | 356 | P30825 | |
| YFPEMERMDLPQGLR | 831 | Q96PX9 | |
| LFRGDFVMDYPRPIM | 256 | P35504 | |
| VIGEMPPAGLYEEIM | 951 | Q4G0T1 | |
| RDIMSIYKEPPPGMF | 106 | Q9H832 | |
| MMERLHLFPDEYIPE | 121 | Q9BYD1 | |
| MPSELEYMIVSFREP | 2516 | Q7Z7G8 | |
| MADMFDGRLEPIVFP | 36 | Q8N831 | |
| YNPMPFELRVENMGL | 606 | Q96Q05 | |
| FGLVIIPEVLMGMPY | 271 | Q8TDI7 | |
| LEYPRPVMPNMVFIG | 261 | P19224 | |
| MTPYALPVIGEVRSM | 246 | Q9H6R7 | |
| IISAPDQLMPYFVME | 311 | Q1EHB4 | |
| LFRGDFVMDYPRPIM | 256 | P22310 | |
| VSMLGYPFILPDMVG | 541 | Q6NSJ0 |